The New US Gold Standard Event for Pharma & Biotech Patent Litigation
ACI’s Forum on Pharma and Biotech Patent Litigation USA brings together leaders in life sciences patent litigation for a two-day deep dive into winning patent litigation strategies. Our highly skilled faculty – comprised of premier in-house and law firm patent litigation counsel – will bring you up to date on the latest challenges in life sciences patent litigation. Attend and gain insights into new legal theories for your patent case in chief, as well as analyses of substantive case law, and practical litigation strategies and takeaways for your next patent trial and proceedings.
This is your one-stop shop for updates, analyses, networking, and strategies to keep you in control of the patent.
Key Highlights
Lightning round session on emerging trends in Hatch-Waxman litigation
Analysis of new Orange Book and related combination product patent concerns
Dance lessons: what steps have we learned through 15 years of BPCIA litigation?
Amgen, Cellect, Amneal, Xencor and More!: Understand how these cases are game changers to your patent litigation strategies
Pharma and biotech patents in antitrust the cross-hairs: looking beyond the settlement to new anticompetitive challenges
Remedies and damages: evaluating at the wide swath of possibilities, options, and penalties for patent infringement
Plus, take part in in-depth strategy brainstorms, where experienced litigators will discuss major challenges in pharma and biotech patent litigation tactics, arming you with the tools you need:
Answering the question, “when is litigation worth it?”
Thorough review of the best choice of forum in view of administrative changes, ranging from procedures at the PTAB to tariff questions which can only be addressed at the ITC
Considering how to utilize expert witnesses properly and effectively as costs continue to rise – from how many to what type to when
Appellate litigation strategies to ensure you’re bringing your best fight to the Federal Circuit – and, possibly, all the way to the Supreme Court
A Must-Attend Event For
In-Housel Counsel and Executives from Pharmaceutical and Biotech Companies, including:
- Head of Patent Litigation/ IP Litigation
- VP-Intellectual Property
- Head, IP
- IP/Patent Counsel
- Head of Legal / Legal Affairs
- Head of Global IP/Patent Strategy
- Director Innovation, IP, and Portfolio Management
- R&D Patent Manager
- Director of Licensing & Commercialization
Law Firm Attorneys with Practices in:
- Life Sciences/ Pharma-Biotech Intellectual Property/ Patent Litigation
- Life Sciences/ Pharma-Biotech Intellectual Property and Patent Law
Earn CLE Credits
Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as non-transitional for the purposes of CLE accreditation.
Learn moreSponsor Opportunities
With conferences in the United States, Europe, Asia Pacific, and Latin America, the C5 Group of Companies: American Conference Institute, the Canadian Institute, and C5 Group, provides a diverse portfolio of conferences, events and roundtables devoted to providing business intelligence to senior decision makers responding to challenges around the world.
For more information please contact:
Aaron Goldstein
Senior Business Development Manager
Email: [email protected]
